澳门威斯人8040com-澳门威尼娱人网站

Company
Introduction

2008

CF PharmTech was founded in Wuxi, Jiangsu province in 2008.

Through rapid growth, it becomes a fully integrated specialty pharmaceutical company dedicated to providing high-quality respiratory drugs for the global market.

Managed by a high-caliber team with extensive experience in the industry, the company focuses on the development of drugs for the treatment of respiratory diseases in its state-of-the-art facilities.

alttext

Our mission

dots Our mission is to develop high-quality and affordable products to treat respiratory diseases and help patients to breathe easier and live better.

alttext

Our values

Integrity

Patient Focus

Science-led Innovation

Our History

  • CF lobby

    2008

    CF PharmTech was founded under Wuxi "530” Sponsorship Program

  • Scientist looking through microscope

    2009

    Received Jiangsu Provincial Innovation Award, and Science and Technology Leader Team Award

  • handshake

    2010

    Secured a A-series capital investment, signed strategic partnership deal with Beijing SL Pharmaceutical

  • People in CF

    2011

    Wholly-owned subsidiary-Jiangsu CF PharmTech was set up in Wuxi; Filed 5 patents in China

  • New CF lobby

    2013

    Secured a B-series capital investment, startup Suzhou CF PharmTech

  • CF Factory

    2014

    Completed the construction of Suzhou CF PharmTech

  • Production line

    2015

    Secured a C-series capital investment, established the nasal spray and DPI production line

  • CF team 1

    2017

    Secured a D-series capital investment of USD65 million

  • CF team 2

    2018

    Secured a E-series capital investment of USD94 million

  • CF team 3

    2020

    Secured a F-series capital investment of USD50 million

  • CF Product

    2021

    Budesonide Suspension for Inhalation and Salbutamol Sulfate inhalation solution were approved for market.

Baidu
sogou